Post by Eram semper rectaIt seems to me that JG's true calling in life is to serve as a bad
example.
I have a purpose: I am going to get rid of you and your fellow idiots
once and for all. You will in the near future be ashamed to even say
that you had anything to do with mathematics.
1. Following intramuscular injection, it must be expected that the gene-
based vaccines will reach the bloodstream and disseminate throughout the
body [1]. We request evidence that this possibility was excluded in pre-
clinical animal models with all three vaccines prior to their approval
for use in humans by the EMA.
2. If such evidence is not available, it must be expected that the
vaccines will remain entrapped in the circulation and be taken up by
endothelial cells. There is reason to assume that this will happen
particularly at sites of slow blood flow, i.e. in small vessels and
capillaries [2]. We request evidence that this probability was excluded
in pre-clinical animal models with all three vaccines prior to their
approval for use in humans by the EMA.
3. If such evidence is not available, it must be expected that during
expression of the vaccines’ nucleic acids, peptides derived from the spike
protein will be presented via the MHC I — pathway at the luminal surface
of the cells. Many healthy individuals have CD8-lymphocytes that recognize
such peptides, which may be due to prior COVID infection, but also to
cross- reactions with other types of Coronavirus [3; 4] [5]. We must
assume that these lymphocytes will mount an attack on the respective
cells. We request evidence that this probability was excluded in pre-
clinical animal models with all three vaccines prior to their approval
for use in humans by the EMA.
4. 1f such evidence is not available, it must be expected that endothelial
damage with subsequent triggering of blood coagulation via platelet
activation will ensue at countless sites throughout the body. We request
evidence that this probability was excluded in pre-clinical animal models
with all three vaccines prior to their approval for use in humans by the
EMA.
5. If such evidence is not available, it must be expected that this will
lead to a drop in platelet counts, appearance of D-dimers in the blood,
and to myriad ischaemic lesions throughout the body including in the
brain, spinal cord and heart. Bleeding disorders might occur in the wake
of this novel type of DIC-syndrome including, amongst other
possibilities, profuse bleedings and haemorrhagic stroke. We request
evidence that all these possibilities were excluded in pre-clinical
animal models with all three vaccines prior to their approval for use in
humans by the EMA.
6. The SARS-CoV-2 spike protein binds to the ACE2 receptor on platelets,
which results in their activation [6]. Thrombocytopenia has been reported
in severe cases of SARS-CoV-2 infection [7]. Thrombocytopenia has also
been reported in vaccinated individuals [8]. We request evidence that the
potential danger of platelet activation that would also lead to
disseminated intravascular coagulation (DIC) was excluded with all three
vaccines prior to their approval for use in humans by the EMA.
7. The sweeping across the globe of SARS-CoV-2 created a pandemic of
illness associated with many deaths. However, by the time of consideration
for approval of the vaccines, the health systems of most countries were no
longer under imminent threat of being overwhelmed because a growing
proportion of the world had already been infected and the worst of the
pandemic had already abated. Consequently, we demand conclusive
evidence that an actual emergency existed at the time of the EMA granting
Conditional Marketing Authorisation to the manufacturers of all three
vaccines, to justify their approval for use in humans by the EMA,
purportedly because of such an emergency.
Should all such evidence not be available, we demand that approval for
use of the gene-based vaccines be withdrawn until all the above issues
have been properly addressed by the exercise of due diligence by the
EMA.